+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Automated External Defibrillator Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5780668
The global automated external defibrillator market size reached a value of USD 1567.4 million in 2022. The market is likely to grow at a rate of 8.8% in the forecast period of 2023-2031 to reach a market value of USD 3329.9 million by 2031. Increasing investments from market players and technological advancements are anticipated to be the market’s primary growth drivers.

Automated External Defibrillator Market: Introduction

The automated external defibrillator (AED) market refers to the market for medical devices used to treat sudden cardiac arrest (SCA) by delivering an electric shock to the heart. AEDs are portable, user-friendly devices that can be used by non-medical personnel to provide immediate defibrillation to someone experiencing SCA. The market is being driven by factors such as an increase in the prevalence of cardiac diseases, advancements in technology, and a growing awareness of the importance of early defibrillation in saving lives.

Automated External Defibrillator Market- Application and Usage

The AED market is primarily used for the treatment of sudden cardiac arrest (SCA). SCA is a condition where the heart suddenly and unexpectedly stops beating, leading to a loss of consciousness and eventually death if not treated promptly. AEDs are designed to be used by non-medical personnel in emergency situations to deliver an electric shock to the heart, which can restore a normal heart rhythm and save a person's life.

AEDs can be used in a variety of settings, including schools, airports, sports arenas, and other public places where there is a risk of sudden cardiac arrest. They can also be used by first responders such as police officers and firefighters, who are often the first to arrive at the scene of a medical emergency.

Automated External Defibrillator Market Segmentations

The market can be categorised into product, type, end user, distribution channel, and region.

Market Breakup by Product

  • Semi-Automated External Defibrillator
  • Fully Automated External Defibrillator

Market Breakup by Type

  • Wearable
  • Non-Wearable
Market Breakup by End User
  • Hospitals
  • Clinics
  • Homecare
  • Others

Market Breakup by Distribution Channels

  • Hospitals
  • Diagnostic Centres
  • Research Laboratories

Automated External Defibrillator Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Automated External Defibrillator Market Scenario

The market is expected to witness significant growth in the coming years. This growth is primarily driven by the increasing incidence of sudden cardiac arrests (SCA) globally and the growing awareness of the importance of early defibrillation in saving lives. In addition, the availability of advanced AEDs that are easy to use by non-medical personnel and the increasing number of public access defibrillation (PAD) programs are also driving the market's growth.

North America dominates the global AED market, owing to the high prevalence of cardiac diseases and favourable reimbursement policies. Europe is the second-largest market for AEDs, followed by the Asia Pacific region, which is expected to witness the highest growth rate during the forecast period. The Asia Pacific region is expected to witness significant growth due to the rising incidence of cardiovascular diseases, increasing healthcare expenditure, and government initiatives to improve emergency medical services.

The COVID-19 pandemic has led to a significant increase in demand for AEDs, as the virus has been found to increase the risk of sudden cardiac arrest in infected patients. This has further highlighted the importance of AEDs in saving lives and led to increased adoption of AEDs in public spaces, homes, and workplaces. However, the pandemic has also led to disruptions in the supply chain and manufacturing processes, leading to a shortage of devices in some regions.

Key Players in the Global Automated External Defibrillator Market

The report gives an in-depth analysis of the key players involved in the Automated External Defibrillator market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Asahi Kasei Corporation
  • Stryker Corporation
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • Mediana Co. Ltd
  • Physio-Control, Inc
  • BPL Medical Technologies
  • Kestra Medical Technologies, Inc
  • ViVest Medical Technology Co., Ltd
  • ZOLL Medical Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Automated External Defibrillator Market Overview
3.1 Global Automated External Defibrillator Market Historical Value (2016-2022)
3.2 Global Automated External Defibrillator Market Forecast Value (2023-2031)
4 Global Automated External Defibrillator Market Landscape
4.1 Global Automated External Defibrillator Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Automated External Defibrillator Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by End User
5 Global Automated External Defibrillator Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Automated External Defibrillator Market Segmentation
6.1 Global Automated External Defibrillator Market by Product
6.1.1 Market Overview
6.1.2 Semi-Automated External Defibrillator
6.1.3 Fully Automated External Defibrillator
6.2 Global Automated External Defibrillator Market by Type
6.2.1 Market Overview
6.2.2 Wearable
6.2.3 Non-Wearable
6.3 Global Automated External Defibrillator Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Homecare
6.3.5 Others
6.4 Global Automated External Defibrillator Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Automated External Defibrillator Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Automated External Defibrillator Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Automated External Defibrillator Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Automated External Defibrillator Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Automated External Defibrillator Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Asahi Kasei Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Stryker Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Nihon Kohden Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Koninklijke Philips NV
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Mediana Co. Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Physio-Control, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BPL Medical Technologies
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Kestra Medical Technologies, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ViVest Medical Technology Co., Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 ZOLL Medical Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Automated External Defibrillator Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Asahi Kasei Corporation
  • Stryker Corporation
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • Mediana Co. Ltd.
  • Physio-Control, Inc.
  • BPL Medical Technologies
  • Kestra Medical Technologies, Inc.
  • ViVest Medical Technology Co., Ltd
  • ZOLL Medical Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Methodology

Loading
LOADING...

Table Information